Generic Biologics Warning From FDA: Implementation Resources Needed

With the expectation that language to establish a generic biologics approval pathway will be included in the FDA Revitalization Act, former FDA commissioner Frank Young warned of the need for adequate resources

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet